Tech Company Financing Transactions
4P-Pharma Funding Round
4P-Pharma closed a $16 million financing round on 4/29/2024. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/29/2024
Transaction Type
Venture Equity
Amount
$16,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to deploy its drug regeneration model and to engage actively external growth opportunities through M&A and licensing-in and accelerate its startup studio model for building a balanced pipeline towards the commercial stage.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Campus de l'Institut Pasteur de Lille 1 rue du Professeur Ca
Lille, 59000
France
Lille, 59000
France
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Established in 2014, 4P-Pharma is a clinical stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.? Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.?
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Revital Rattenbach
Chief Financial Officer
Jérôme Vailland
Browse more venture capital transactions:
Prev: 4/29/2024: Shinkei Systems venture capital transaction
Next: 4/29/2024: BioIntelligence Technologies venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs